Published in Antimicrob Agents Chemother on January 01, 2003
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 0.92
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. Antimicrob Agents Chemother (2012) 0.81
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. Antimicrob Agents Chemother (2004) 0.81
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. Antimicrob Agents Chemother (2004) 0.78
Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis (1998) 3.76
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995. Antimicrob Agents Chemother (2001) 3.23
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother (1999) 2.33
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis (2000) 1.69
Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob Agents Chemother (2001) 1.59
Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother (1999) 1.55
Antipneumococcal activity of ABT-773 compared to those of 10 other agents. Antimicrob Agents Chemother (2000) 1.48
Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob Agents Chemother (2001) 1.38
Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics (1998) 1.32
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol (2000) 1.29
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19
Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J (2001) 0.94
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Treatment of acute otitis media in children under 2 years of age. N Engl J Med (2011) 10.39
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med (2003) 6.42
Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis (2011) 5.58
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 4.71
Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med (2002) 3.96
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics (2004) 3.71
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis (2004) 3.35
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol (2007) 3.25
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis (2005) 3.21
Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 3.16
Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics (2005) 3.13
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J (2004) 2.91
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media. Pediatr Infect Dis J (2009) 2.60
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J (2002) 2.47
IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis (2012) 2.43
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2005) 2.28
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics (2006) 2.17
Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg (2011) 2.13
Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother (2002) 2.12
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2006) 2.10
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2013) 1.90
The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol (2005) 1.88
Does this child have a urinary tract infection? JAMA (2007) 1.86
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics (2010) 1.77
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J (2003) 1.76
Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Pediatrics (2007) 1.72
Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J (2003) 1.70
Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med (2002) 1.66
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J (2007) 1.65
Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J (2007) 1.65
A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther (2011) 1.62
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J (2006) 1.57
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother (2005) 1.57
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol (2009) 1.55
Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J (2013) 1.52
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J (2004) 1.52
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics (2004) 1.45
Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine (2010) 1.44
Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother (2007) 1.44
Ecthyma gangrenosum: considerations in a previously healthy child. Pediatr Infect Dis J (2002) 1.44
Management of complicated shunt infections: a clinical report. J Neurosurg Pediatr (2008) 1.42
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics (2006) 1.41
Staghorn calculus endotoxin expression in sepsis. Urology (2002) 1.41
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J (2007) 1.41
Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect (2012) 1.40
What is the appropriate treatment course for bacterial arthritis in children? Clin Infect Dis (2009) 1.39
Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J (2004) 1.39
Hepatosplenic cat-scratch fever. Lancet Infect Dis (2008) 1.38
Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am (2009) 1.37
Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol (2010) 1.36
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33
The changing face of pleural empyemas in children: epidemiology and management. Pediatrics (2004) 1.29
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
Multicenter surveillance of invasive meningococcal infections in children. Pediatrics (2006) 1.27
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J (2005) 1.27
The use of systemic and topical fluoroquinolones. Pediatrics (2011) 1.25
Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis (2003) 1.25
Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics (2004) 1.25
Evaluation of acoustical conditions for speech communication in working elementary school classrooms. J Acoust Soc Am (2008) 1.22
Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J (2002) 1.22
Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics (2008) 1.20
Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis (2003) 1.19
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Putting it together: finding success in behavior change through integration of services. Ann Fam Med (2005) 1.16
Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J (2003) 1.14